Virbac SA (VRBCF)

USD 339.23

(0.0%)

Revenue Summary of Virbac SA

  • Virbac SA's latest annual revenue in 2023 was 1.24 Billion EUR , up 2.53% from previous year.
  • Virbac SA's latest quarterly revenue in 2024 Q2 was 351.46 Million EUR , down 0.0% from previous quarter.
  • Virbac SA reported a annual revenue of 1.21 Billion EUR in annual revenue 2022, up 14.31% from previous year.
  • Virbac SA reported a annual revenue of 1.06 Billion EUR in annual revenue 2021, up 13.89% from previous year.
  • Virbac SA reported a quarterly revenue of 351.46 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • Virbac SA reported a quarterly revenue of 1.24 Billion EUR for 2023 FY, up 2.53% from previous quarter.

Annual Revenue Chart of Virbac SA (2023 - 2002)

Historical Annual Revenue of Virbac SA (2023 - 2002)

Year Revenue Revenue Growth
2023 1.24 Billion EUR 2.53%
2022 1.21 Billion EUR 14.31%
2021 1.06 Billion EUR 13.89%
2020 934.19 Million EUR -0.44%
2019 938.34 Million EUR 7.99%
2018 868.93 Million EUR 0.82%
2017 861.88 Million EUR -1.14%
2016 871.82 Million EUR 2.25%
2015 852.62 Million EUR 10.28%
2014 773.11 Million EUR 5.03%
2013 736.07 Million EUR 5.89%
2012 695.15 Million EUR 11.57%
2011 623.05 Million EUR 8.77%
2010 572.83 Million EUR 22.55%
2009 467.41 Million EUR 5.43%
2008 443.35 Million EUR 1.1%
2007 438.54 Million EUR 9.19%
2006 401.63 Million EUR 7.85%
2005 372.4 Million EUR 5.98%
2004 351.4 Million EUR -0.95%
2003 354.75 Million EUR -3.58%
2002 367.93 Million EUR 0.0%

Peer Revenue Comparison of Virbac SA

Name Revenue Revenue Difference
AstraZeneca PLC 46.91 Billion USD 97.342%
Bristol-Myers Squibb Company PFD CONV 2 45 Billion USD 97.229%
CSPC Pharmaceutical Group Limited 31.45 Billion USD 96.035%
Clarus Therapeutics Holdings, Inc. 13.95 Million USD -8833.875%
Novartis AG 46.66 Billion USD 97.328%
PT Kalbe Farma Tbk. 1.97 Billion USD 37.0%